168 related articles for article (PubMed ID: 24618093)
21. Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma.
Tirumani SH; LaCasce AS; Jacene HA
PET Clin; 2015 Apr; 10(2):207-25. PubMed ID: 25829087
[TBL] [Abstract][Full Text] [Related]
22. FDG PET/CT leads to the detection of metastatic involvement of the heart in non-Hodgkin's lymphoma.
Julian A; Wagner T; Ysebaert L; Chabbert V; Payoux P
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1174. PubMed ID: 21431399
[No Abstract] [Full Text] [Related]
23. Spectrum of malignant pleural and pericardial disease on FDG PET/CT.
Makis W; Ciarallo A; Hickeson M; Rush C; Novales-Diaz JA; Derbekyan V; Laufer J; Stern J; Lisbona R
AJR Am J Roentgenol; 2012 Mar; 198(3):678-85. PubMed ID: 22358009
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
[TBL] [Abstract][Full Text] [Related]
25. (18)F-FDG PET/CT in an unusual case of cardiac plexiform neurofibromatosis.
D'souza MM; Sondhi P; D'souza P; Sharma R; Jaimini A; Pandey S; Mondal A; Tripathi RP
Clin Nucl Med; 2015 Jun; 40(6):529-30. PubMed ID: 25706790
[TBL] [Abstract][Full Text] [Related]
26. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
[TBL] [Abstract][Full Text] [Related]
27. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
Yamane T; Daimaru O; Ito S; Nagata T; Yoshiya K; Fukaya N; Ito S; Imai T; Uchida H
Ann Nucl Med; 2008 Oct; 22(8):719-22. PubMed ID: 18982476
[TBL] [Abstract][Full Text] [Related]
28. The role of PET in lymphoma.
Jhanwar YS; Straus DJ
J Nucl Med; 2006 Aug; 47(8):1326-34. PubMed ID: 16883013
[TBL] [Abstract][Full Text] [Related]
29. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H
J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444
[TBL] [Abstract][Full Text] [Related]
31. High liver FDG uptake on PET/CT in patient with lymphoma diagnosed with hereditary hemochromatosis.
Infante JR; Moreno M; Rayo JI; Serrano J; Dominguez ML; Garcia L
Clin Nucl Med; 2015 Jun; 40(6):538-9. PubMed ID: 25608173
[TBL] [Abstract][Full Text] [Related]
32. [PET/CT Image Values in Clinical Staging of the Patients with Non-Hodgkin's Lymphoma].
Tang HJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1030-3. PubMed ID: 26314440
[TBL] [Abstract][Full Text] [Related]
33. Comparison of CT, PET, and PET/CT for staging of patients with indolent non-hodgkin's lymphoma: statistical errors in Fueger et al. (2009).
White LR
Mol Imaging Biol; 2012 Aug; 14(4):397-8; author reply 399-401. PubMed ID: 21814856
[No Abstract] [Full Text] [Related]
34. Impact of (18)F-FDG PET/CT on the staging and management of follicular lymphoma.
Metser U; Hussey D; Murphy G
Br J Radiol; 2014 Oct; 87(1042):20140360. PubMed ID: 25061910
[TBL] [Abstract][Full Text] [Related]
35. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
[TBL] [Abstract][Full Text] [Related]
36. Commentary: PET poised to alter the current paradigm for response assessment of non-Hodgkin's lymphoma.
Guermazi A; Juweid ME
Br J Radiol; 2006 May; 79(941):365-7. PubMed ID: 16632614
[No Abstract] [Full Text] [Related]
37. Peritoneal lymphomatosis found on 18F-FDG PET/CT.
van Rheenen RW; Bongaerts AH; Glaudemans AW
Eur J Haematol; 2012 Dec; 89(6):503-4. PubMed ID: 22712752
[No Abstract] [Full Text] [Related]
38. PET/CT appearance of non-Hodgkin lymphoma of the vermiform appendix.
Souza FF; Israel DA
Clin Nucl Med; 2008 Oct; 33(10):694-6. PubMed ID: 18806571
[No Abstract] [Full Text] [Related]
39. Current role of FDG PET/CT in lymphoma.
Kostakoglu L; Cheson BD
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):1004-27. PubMed ID: 24519556
[TBL] [Abstract][Full Text] [Related]
40. Advanced Hodgkin's lymphoma: End-of-treatment FDG-PET should be maintained.
Hindié E; Mesguich C; Bouabdallah K; Milpied N
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1254-1257. PubMed ID: 28466283
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
